Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-08-18
2000-09-19
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514314, 546170, A61K 3147, C07D21554
Patent
active
061212849
ABSTRACT:
The present invention relates to new 2,3-bridged 1,4-dihydropyridines of the general formula (I), ##STR1## in which R, R.sup.1, R.sup.2, D and E have the meaning given in the description, processes for their preparation and their use as medicaments, preferably for treatment of the central nervous system.
REFERENCES:
patent: 4021434 (1977-05-01), Murakami et al.
patent: 4720572 (1988-01-01), Stubbe
patent: 5328931 (1994-07-01), Rosen et al.
J.C. Ellory, et al., Br. J. Pharmacol., vol. 111, pp. 903-905, (1994).
J.C. Ellory, et al., Br. J. Pharmacol., vol. 106, pp. 972-977, (1992).
J.C. Ellory, et al., FEBS, vol. 296, No. 2, pp. 219-221, (1992).
U. Rose, Arzneim.-Forsch./Drug Res., vol. 41, No. 3, pp. 199-203, (1991).
P.W.L. Tas, et al., Neuroscience Letters, vol. 94, pp. 279-284, (1988).
Zandersons et. al., J. Chem. Res. Miniprint, vol. 9, p. 2401-2410 (1993)-(Print-out from File Beilstein Search Provided).
de Vry Jean-Marie-Viktor
Glaser Thomas
Goldmann Siegfried
Heine Hans-Georg
Junge Bodo
Bayer Aktiengesellschaft
Dentz Bernard
LandOfFree
2,3-bridged 1,4-dihydropyridines, and their use as medicaments does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,3-bridged 1,4-dihydropyridines, and their use as medicaments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,3-bridged 1,4-dihydropyridines, and their use as medicaments will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1073570